Compare APLE & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APLE | ITGR |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.3B |
| IPO Year | 2007 | 2000 |
| Metric | APLE | ITGR |
|---|---|---|
| Price | $18.93 | $126.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 9 |
| Target Price | $17.78 | ★ $127.00 |
| AVG Volume (30 Days) | ★ 2.3M | 775.9K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | ★ 5.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.66 | ★ 1.60 |
| Revenue | $1,238,622,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $3.43 | N/A |
| Revenue Next Year | $2.15 | $5.97 |
| P/E Ratio | ★ $47.05 | $79.15 |
| Revenue Growth | ★ 18.98 | 7.98 |
| 52 Week Low | $11.32 | $66.51 |
| 52 Week High | $18.98 | $126.83 |
| Indicator | APLE | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 59.03 |
| Support Level | $15.97 | $126.50 |
| Resistance Level | $18.98 | $126.80 |
| Average True Range (ATR) | 0.46 | 0.17 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 77.14 | 31.34 |
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.